Biocon Jumps 3% as Insulin Facility in Malaysia gets GMP Nod

Posted By: Religare
Subscribe to GoodReturns

Shares of Biocon soared over 3 per cent on the Bombay Stock Exchange after the company said that its insulin facility in Malaysia received compliance certificate.

Biocon Jumps 3% as Insulin Facility in Malaysia gets GMP Nod
Biocon: Quotes, News
BSE 569.85BSE Quote30.25 (5.31%)
NSE 569.35NSE Quote29.75 (5.23%)

Biocon said its subsidiary in Malaysia, Biocon Sdn. Bhd., received a certificate of 'GMP (Good Manufacturing Practice) Compliance' for its Insulins manufacturing facility by the HPRA (Ireland) as the representative European inspection authority.

Following the statement, shares of the company gained as much as 3.18 per cent to trade at Rs 345.80 apiece on the Bombay Stock Exchange.

In a similar fashion, shares of the company were trading 3.24 per cent higher at Rs 345.60 apiece on the National Stock Exchange.

Meanwhile, the broader benchmark BSE Sensex was trading at 31,711.70, up 48.96 points, or 0.15 per cent, at 11:55 hours.

Read more about: biocon
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'


Get Latest News alerts from Goodreturns